Multidetector CT evaluation of the course of nonresectable pancreatic carcinomas with neoadjuvant tsherapy

Pancreatology

Volumn 9, Issue 5, 2009, Pages 621-630

  Klauss, M ^a   Alt, C D ^a   Welzel, T ^a   Werner, J ^a   Buchler M W ^a   Richter, G M ^a   Kauffmann, G W ^a   Kauczor, H U ^a   Grenacher, L ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Assessment during therapy; Computed tomography; Neoadjuvant therapy; Pancreatic carcinoma; Vessel infiltration score

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CISPLATIN; GEMCITABINE; IOPROMIDE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SIZE; CELIAC ARTERY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FEMALE; FOLLOW UP; HEPATIC ARTERY; HUMAN; HUMAN TISSUE; INOPERABLE CANCER; INTENSITY MODULATED RADIATION THERAPY; LIVER METASTASIS; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PANCREAS CARCINOMA; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SUPERIOR MESENTERIC VEIN; TUMOR BIOPSY; VASCULAR TUMOR;

EID: 68049104003     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000212096     Document Type: Article

References (22)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-130.
2. Kleeff J, Michalski C, Friess H, Buchler MW: Pancreatic cancer: from bench to 5-year survival. Pancreas 2006; 33: 111-118.
3. Kim R, Saif MW: Is there an optimal neoadjuvant therapy for locally advanced pancreatic cancer? JOP 2007; 8: 279-288. (Pubitemid 46876786)
4. Bold RJ, Charnsangavej C, Cleary KR, et al: Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis. J Gastrointest Surg 1999; 3: 233-243.
5. Kleeff J, Friess H, Buchler MW: Neoadjuvant therapy for pancreatic cancer. Br J Surg 2007; 94: 261-262.
6. NCCN: NCCN guidelines for treatment of pancreatic cancer 2006. In: www.nccn.org/ professionals/physician-gls/PDF/pancreatic. pdf, 2006.
7. Chao C, Hoffman JP, Ross EA, Torosian MH, Eisenberg BL: Pancreatic carcinoma deemed unresectable at exploration may be resected for cure: an institutional experience. Am Surg 2000; 66: 378-385, discussion 386.
8. Beger HG, Poch B, Schwarz M, Gansauge F: Pancreatic cancer: the relative importance of neoadjuvant therapy. Chirurg 2003; 74: 202-207.
9. Seufferlein T, von Wichert G, Adler G: Palliative treatment of pancreatic cancer. Dtsch Med Wochenschr 2007; 132: 813-817. (Pubitemid 46739676)
10. Schima W, Ba-Ssalamah A, Kolblinger C, Kulinna-Cosentini C, Puespoek A, Gotzinger P: Pancreatic adenocarcinoma. Eur Radiol 2007; 17: 638-649.
11. Schima W, Ba-Ssalamah A, Plank C, et al: Pancreas. II. Tumors. Radiologe 2006; 46: 421-437.
12. Catalano C, Laghi A, Fraioli F, et al: Pancreatic carcinoma: the role of high-resolution multislice spiral CT in the diagnosis and assessment of resectability. Eur Radiol 2003; 13: 149-156.
13. Brugel M, Link TM, Rummeny EJ, Lange P, Theisen J, Dobritz M: Assessment of vascular invasion in pancreatic head cancer with multislice spiral CT: value of multiplanar reconstructions. Eur Radiol 2004; 14: 1188-1195.
14. Klauss M, Mohr A, von Tengg-Kobligk H, Friess H, Singer R, Seidensticker P, Kauczor HU, Richter GM, Kauffmann GW, Grenacher L: A new invasion score for determining the resectability of pancreatic carcinomas with contrast-enhanced multidetector computed tomography. Pancreatology 2008; 8: 204-210.
15. Richter GM, Simon C, Hoffmann V, et al: Hydrospiral CT of the pancreas in thin section technique. Radiologe 1996; 36: 397-405.
16. Richter GM, Wunsch C, Schneider B, et al: Hydro-CT in detection and staging of pancreatic carcinoma. Radiologe 1998; 38: 279-286.
17. Li H, Zeng MS, Zhou KR, Jin DY, Lou WH: Pancreatic adenocarcinoma: the different CT criteria for peripancreatic major arterial and venous invasion. J Comput Assist Tomogr 2005; 29: 170-175.
18. Kundel HL, Polansky M: Measurement of observer agreement. Radiology 2003; 228: 303-308.
19. Bland JM, Altman DG: Measuring agreement in method comparison studies. Stat Methods Med Res 1999; 8: 135-160.
20. Burris HA 3rd, Moore MJ, Andersen J, et al: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997; 15: 2403-2413.
21. Tamm EP, Loyer EM, Faria S, et al: Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy. Abdom Imaging 2006; 31: 568-574.
22. Vargas R, Nino-Murcia M, Trueblood W, Jeffrey RB Jr: MDCT in Pancreatic adenocarcinoma: prediction of vascular invasion and resectability using a multiphasic technique with curved planar reformations. AJR Am J Roentgenol 2004; 182: 419-425.